Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Diamedica Therapeutics (DMAC) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 10 quarters since 2019. Compare with DMAC stock chart to see long term trends.

DMAC stock compared to

DMAC Income Statement

Research & Development Expense:2156000
Operating Income:-3365000
Income Taxes:7000
Net Income:-3274000
Earnings Per Share, Basic:-0.17
Shares Outstanding, Basic Avg:18786157

DMAC Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:-321000
Net Cash from Operations:-2089000
Net Cash from Financing Activities:-1000
Property, Plant & Equipment Purchases:4000
Net Cash from Investing Activities:989000
Net Change in Cash & Equivalents:-1101000

DMAC Balance Sheet

Cash and Cash Equivalents:2228000
Short-Term Investments:19067000
Accounts Receivable, Net:16000
Total Current Assets:21629000
Property, Plant & Equipment, Net:73000
Total Assets:21774000
Accounts Payable:239000
Total Short-Term Liabilities:1440000

Insider Trading

Change
Value
Transaction
SEC Form 4
Burroughs Amy L.   Director
44,950 sh at $3
$141,593
Buy
Pilnik Richard D.   Director
15,000 sh at $3
$49,064
Buy
ALCORN HARRY W JR   Senior VP, Clinical Operations
20,322 sh at $3
$62,829
Buy
Kellen Scott   CFO and Secretary
10,000 sh at $3
$31,463
Buy
Pauls Dietrich John   President and CEO
5,000 sh at $3
$15,700
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Stonepine Capital Management, LLC
1,023,409 sh
 
$9,364
Vanguard Group Inc
786,266 sh
-60,047 sh
-7%
$3,499
-$4,245
Manatuck Hill Partners, LLC
570,500 sh
 
$2,539
Stonepine Capital Management, LLC
419,942 sh
-603,467 sh
-59%
$1,869
-$7,495
Ikarian Capital, LLC
415,000 sh
 
$1,847
Corriente Advisors, LLC
203,641 sh
-666,587 sh
-77%
$906
-$7,057
Marshall Wace, Llp
155,662 sh
79,695 sh
105%
$693
-$2
Bank Of Montreal /Can/
142,846 sh
38,322 sh
37%
$694
-$288
Geode Capital Management, LLC
133,569 sh
5,101 sh
4%
$594
-$581
Renaissance Technologies LLC
94,100 sh
-59,000 sh
-39%
$419
-$982
Northern Trust Corp
85,195 sh
169 sh
0%
$379
-$399
Blackrock Inc.
61,259 sh
1,094 sh
2%
$273
-$278
Cooperman Leon G
50,000 sh
 
$223
Susquehanna International Group, Llp
Put options for 47,200 sh
47,200 sh
NEW
$210
$210
Susquehanna International Group, Llp
47,165 sh
47,165 sh
NEW
$210
$210
Boothbay Fund Management, LLC
46,562 sh
 
$207
Bank Of New York Mellon Corp
38,284 sh
-2,292 sh
-6%
$170
-$201
Two Sigma Securities, LLC
30,511 sh
30,511 sh
NEW
$136
$136
State Street Corp
30,217 sh
30,217 sh
NEW
$134
$134
Citadel Advisors LLC
25,398 sh
4,797 sh
23%
$113
-$76

Data imported from Diamedica Therapeutics Inc SEC filings. Check original filings before making any investment decision.